Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma. uri icon

Overview

publication date

  • May 9, 2022

Research

keywords

  • Exanthema
  • Multiple Myeloma

Identity

PubMed Central ID

  • PMC9680041

Scopus Document Identifier

  • 85130132910

Digital Object Identifier (DOI)

  • 10.1080/10428194.2022.2068002

PubMed ID

  • 35532206

Additional Document Info

volume

  • 63

issue

  • 9